Showing results (211-220 of 650) with videos related to
Sort By:
Pageof 65
Developmental Neurobiology|July 26, 2014
Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic functionAbigail Mariga, Jiri Zavadil, Stephen D Ginsberg, et al.Stroke|November 1, 1986
Increased cerebral blood flow during hypercapnia is not affected by lesion of the nucleus locus ceruleusS I Harik, R Prado, R Busto, et al.Acta Neuropathologica|May 26, 1998
Sequential analysis of subacute and chronic neuronal, astrocytic and microglial alterations after transient global ischemia in ratsB Lin, M D Ginsberg, R Busto, et al.Molecular Brain|November 10, 2010
Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's diseaseLatha Devi, Melissa J Alldred, Stephen D Ginsberg, et al.Stroke|November 23, 2007
Albumin therapy improves local vascular dynamics in a rat model of primary microvascular thrombosis: a two-photon laser-scanning microscopy studyAnitha Nimmagadda, Hee-Pyoung Park, Ricardo Prado, et al.Brain Research|January 23, 1997
Hyperthermia enhances spectrin breakdown in transient focal cerebral ischemiaT Morimoto, M D Ginsberg, W D Dietrich, et al.Eneuro|January 2, 2024
Dentate Gyrus Granule Cells Show Stability of BDNF Protein Expression in Mossy Fiber Axons with Age, and Resistance to Alzheimer's Disease Neuropathology in a Mouse ModelChiara Criscuolo, Elissavet Chartampila, Stephen D Ginsberg, et al.Brain Research|December 8, 1995
Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative studyL Belayev, R Busto, B D Watson, et al.Acta Neuropathologica|April 20, 1999
Progressive parenchymal deposition of beta-amyloid precursor protein in rat brain following global cerebral ischemiaB Lin, R Schmidt-Kastner, R Busto, et al.Journal of Child and Adolescent Psychopharmacology|December 29, 2009
Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: an open-label, dose-optimization studyRobert L Findling, Lawrence D Ginsberg, Rakesh Jain, et al.Pageof 65